V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20023853 | 20010128 | 1.63 | 67.5 | Adjuvant (A) | 2015-11-26 | 2015-11-27 | FEC 100 + DOCETAXEL | 02 | null | 20084321 | FEC + DOCETAXEL |
| 20023854 | 20010128 | 1.65 | 68.6 | Adjuvant (A) | 2014-04-30 | 2014-05-06 | FEC + DOCETAXEL | N | N | 20084321 | FEC + DOCETAXEL |
| 20023855 | 20010129 | 1.61 | null | Adjuvant (A) | null | 2016-10-13 | FEC + DOCETAXEL | N | N | 20084346 | FEC + DOCETAXEL |
| 20023856 | 20010129 | 1.61 | 85 | Adjuvant (A) | 2013-10-31 | 2013-11-02 | FEC 100 + DOCETAXEL | 2 | N | 20084346 | FEC + DOCETAXEL |
| 20023857 | 20010130 | 1.62 | 76 | Adjuvant (A) | 2014-08-24 | 2014-09-05 | FEC + DOCETAXEL | 02 | N | 20084357 | FEC + DOCETAXEL |
| 20023858 | 20010130 | 1.58 | 63 | Adjuvant (A) | 2014-07-24 | 2014-08-01 | FEC + DOCETAXEL | 99 | null | 20084357 | FEC + DOCETAXEL |
| 20023859 | 20010131 | null | 55.8 | Adjuvant (A) | 2013-12-26 | 2013-12-31 | FEC 100 + DOCETAXEL | 2 | N | 20084360 | FEC + DOCETAXEL |
| 20023860 | 20010131 | null | 68.5 | Neo-adjuvant (N) | null | 2014-07-22 | FEC 100 + DOCETAXEL | N | N | 20084360 | FEC + DOCETAXEL |
| 20023861 | 20010132 | 1.71 | 78.9 | Curative (C) | 2016-07-03 | 2016-07-03 | FEC + DOCETAXEL | 2 | N | 20084378 | FEC + DOCETAXEL |
| 20023862 | 20070839 | 1.54 | 77.3 | Adjuvant (A) | 2016-08-30 | 2016-09-02 | FEC + DOCETAXEL | 02 | N | 20084384 | FEC + DOCETAXEL |
| 20023863 | 20010133 | 1.67 | 71.2 | Adjuvant (A) | 2017-05-17 | 2017-05-28 | FEC + DOCETAXEL | 02 | N | 20084385 | FEC + DOCETAXEL |
| 20023864 | 20010133 | 1.72 | 99.8 | Neo-adjuvant (N) | 2014-02-02 | 2014-01-25 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | null | 20084385 | FEC + DOCETAXEL |
| 20023865 | 20010133 | 1.48 | 69.1 | Adjuvant (A) | null | 2013-08-06 | FEC 100 + DOCETAXEL | null | null | 20084385 | FEC + DOCETAXEL |
| 20023866 | 20010134 | 0 | 107.4 | Curative (C) | 2013-09-15 | 2013-09-24 | FEC 100 + DOCETAXEL | 2 | N | 20084391 | FEC + DOCETAXEL |
| 20023867 | 20010134 | null | null | Adjuvant (A) | 2014-11-29 | 2014-12-13 | FEC + DOCETAXEL | 2 | N | 20084391 | FEC + DOCETAXEL |
| 20023868 | 20010134 | 1.68 | 76.3 | Not known (9) | 2015-10-27 | 2015-11-01 | FEC 100 + DOCETAXEL | 02 | N | 20084391 | FEC + DOCETAXEL |
| 20023869 | 20010134 | 1.68 | 60.6 | Adjuvant (A) | 2013-04-18 | 2013-04-30 | FEC + DOCETAXEL | null | null | 20084391 | FEC + DOCETAXEL |
| 20023870 | 20010134 | null | 61 | Adjuvant (A) | 2016-10-01 | 2016-10-29 | FEC 100 + DOCETAXEL | 2 | N | 20084391 | FEC + DOCETAXEL |
| 20023871 | 20010135 | 1.63 | 67 | Neo-adjuvant (N) | 2017-10-27 | 2017-11-09 | FEC + DOCETAXEL | 02 | N | 20084421 | FEC + DOCETAXEL |
| 20023872 | 20010136 | 1.65 | 79.3 | Adjuvant (A) | 2017-11-23 | 2017-11-27 | FEC + DOCETAXEL | 2 | N | 20084432 | FEC + DOCETAXEL |
| 20023873 | 20010136 | null | 90 | Adjuvant (A) | 2017-10-21 | 2017-11-04 | FEC 100 + DOCETAXEL | N | N | 20084432 | FEC + DOCETAXEL |
| 20023874 | 20010137 | null | null | Neo-adjuvant (N) | 2016-02-19 | 2016-03-15 | FEC + DOCETAXEL | N | N | 20084440 | FEC + DOCETAXEL |
| 20023875 | 20010137 | 1.47 | 72.2 | Adjuvant (A) | 2013-04-08 | 2013-04-29 | FEC + DOCETAXEL | 02 | N | 20084440 | FEC + DOCETAXEL |
| 20023876 | 20010137 | 1.61 | 75 | Not known (9) | 2016-07-27 | 2016-07-27 | FEC + DOCETAXEL | 02 | N | 20084440 | FEC + DOCETAXEL |
| 20023877 | 20010137 | 1.65 | 47 | Neo-adjuvant (N) | 2016-04-04 | 2016-04-04 | FEC + DOCETAXEL | 02 | N | 20084440 | FEC + DOCETAXEL |
| 20023878 | 20010137 | null | null | Adjuvant (A) | 2014-04-25 | 2014-05-02 | FEC + DOCETAXEL | N | N | 20084440 | FEC + DOCETAXEL |
| 20023879 | 20010138 | 1.55 | 74.2 | Curative (C) | 2015-11-01 | 2015-11-23 | FEC + DOCETAXEL | N | N | 20084455 | FEC + DOCETAXEL |
| 20023880 | 20010139 | 1.52 | 71.45 | Adjuvant (A) | 2016-11-30 | 2017-01-03 | FEC + DOCETAXEL | N | N | 20084458 | FEC + DOCETAXEL |
| 20023881 | 20010140 | null | 61.6 | Adjuvant (A) | null | 2016-06-30 | FEC 100 + DOCETAXEL | null | null | 20084460 | FEC + DOCETAXEL |
| 20023882 | 20010141 | null | 74.3 | Adjuvant (A) | 2013-05-17 | 2013-06-02 | FEC 60 OR 75 + DOCETAXEL | N | N | 20084466 | FEC + DOCETAXEL |
| 20023883 | 20010142 | 1.62 | 82.6 | null | 2013-08-22 | 2013-08-29 | FEC 100 + DOCETAXEL | N | N | 20084467 | FEC + DOCETAXEL |
| 20023884 | 20010143 | 1.59 | 78.7 | Adjuvant (A) | 2013-12-26 | 2013-12-26 | FEC + DOCETAXEL | 02 | N | 20084470 | FEC + DOCETAXEL |
| 20023885 | 20010143 | 1.72 | 82.5 | Curative (C) | 2013-06-24 | 2013-06-24 | FEC + DOCETAXEL | 02 | null | 20084470 | FEC + DOCETAXEL |
| 20023886 | 20010143 | 1.6 | 78.2 | Curative (C) | 2016-12-07 | 2016-12-09 | FEC + DOCETAXEL | 2 | Y | 20084470 | FEC + DOCETAXEL |
| 20023887 | 20010143 | null | 64 | Adjuvant (A) | 2014-11-06 | 2014-11-27 | FEC + DOCETAXEL | null | null | 20084470 | FEC + DOCETAXEL |
| 20023888 | 20010144 | 1.66 | 92 | Adjuvant (A) | 2016-05-30 | 2016-06-07 | FEC 100 + DOCETAXEL | 2 | N | 20084486 | FEC + DOCETAXEL |
| 20023889 | 20070845 | 1.72 | 82.4 | Curative (C) | 2015-03-08 | 2015-04-03 | FEC 100 + DOCETAXEL | N | N | 20084492 | FEC + DOCETAXEL |
| 20023890 | 20010145 | null | 62.3 | Adjuvant (A) | null | 2017-12-25 | FEC 100 + DOCETAXEL | null | null | 20084500 | FEC + DOCETAXEL |
| 20023891 | 20010145 | 1.67 | 98 | Neo-adjuvant (N) | 2013-06-12 | 2013-06-19 | FEC + DOCETAXEL | 02 | null | 20084500 | FEC + DOCETAXEL |
| 20023892 | 20010145 | 1.56 | 64 | Adjuvant (A) | null | 2016-08-13 | FEC 100 + DOCETAXEL | N | N | 20084500 | FEC + DOCETAXEL |
| 20023893 | 20010146 | 1.71 | 64.7 | Not known (9) | 2016-08-11 | 2016-08-18 | FEC + DOCETAXEL | 02 | N | 20084506 | FEC + DOCETAXEL |
| 20023894 | 20070847 | 1.68 | 87.35 | Adjuvant (A) | 2014-03-29 | 2014-04-08 | FEC + DOCETAXEL | 2 | N | 20084517 | FEC + DOCETAXEL |
| 20023895 | 20070847 | 1.56 | 65.8 | Neo-adjuvant (N) | null | 2014-03-14 | FEC + DOCETAXEL | N | N | 20084517 | FEC + DOCETAXEL |
| 20023896 | 20070847 | 1.63 | 70.6 | Adjuvant (A) | 2014-02-26 | 2014-03-10 | FEC + DOCETAXEL | 02 | N | 20084517 | FEC + DOCETAXEL |
| 20023897 | 20137777 | 1.77 | 103.8 | Adjuvant (A) | 2014-07-30 | 2014-08-19 | FEC + DOCETAXEL | 2 | N | 20084527 | FEC + DOCETAXEL |
| 20023898 | 20010147 | 1.64 | 55 | Curative (C) | 2016-12-14 | 2016-12-28 | FEC + DOCETAXEL | 01 | null | 20084535 | FEC + DOCETAXEL |
| 20023899 | 20010147 | 1.63 | 58 | Adjuvant (A) | 2018-02-23 | 2018-03-02 | FEC + DOCETAXEL | 2 | N | 20084535 | FEC + DOCETAXEL |
| 20023900 | 20010147 | 1.53 | 62.6 | Adjuvant (A) | 2013-06-23 | 2013-06-28 | FEC 100 + DOCETAXEL | 02 | N | 20084535 | FEC + DOCETAXEL |
| 20023901 | 20010148 | null | 94 | Adjuvant (A) | 2015-05-27 | 2015-06-02 | FEC + DOCETAXEL | null | null | 20084547 | FEC + DOCETAXEL |
| 20023902 | 20010149 | null | 73.6 | Adjuvant (A) | 2018-01-06 | 2018-02-13 | FEC + DOCETAXEL | N | N | 20084548 | FEC + DOCETAXEL |